Skip to main content
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.120
-0.180 (-4.19%)
At close: Mar 9, 2026, 4:00 PM EDT
4.112
-0.008 (-0.19%)
After-hours: Mar 9, 2026, 4:38 PM EDT

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $2.17M in the quarter ending September 30, 2025, with 90.10% growth. This brings the company's revenue in the last twelve months to $5.20M, down -46.88% year-over-year. In the year 2024, Bolt Biotherapeutics had annual revenue of $7.69M, down -2.36%.

Revenue (ttm)
$5.20M
Revenue Growth
-46.88%
P/S Ratio
1.59
Revenue / Employee
$129,875
Employees
40
Market Cap
7.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.69M-186.00K-2.36%
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CollPlant Biotechnologies 2.48M
SeaStar Medical Holding 881.00K
Iterum Therapeutics 390.00K
Addex Therapeutics 198.82K
Alaunos Therapeutics 6.00K
Ernexa Therapeutics 1,000.00
Revenue Rankings

BOLT News

More News